The myeloprotective effect of high dose medroxyprogesterone acetate (HD-MPA) in patients with carcinoma of the uterine cervix (stage II & III) treated by radiation
Saved in:
Main Author: | Supatra Sangruchi |
---|---|
Other Authors: | Mahidol University |
Format: | Article |
Published: |
2018
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/17661 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Relationship Histopathology Grading of Meningioma with the Use of Medroxyprogesterone Acetate (MPA) as A Hormonal Contraceptive
by: Shafhan Dustur, -, et al.
Published: (2022) -
Blue nevus of the uterine cervix.
by: M. Rochanawutanon
Published: (2018) -
Depot‐medroxyprogesterone acetate (dmpa) and risk of edometrial cancer
by: Suporn Silpisornkosol, et al.
Published: (2018) -
Depot‐medroxyprogesterone acetate (DMPA) and risk of liver cancer
by: J. G. Mati, et al.
Published: (2018) -
High-dose-rate interstitial brachytherapy in the management of carcinoma of the uterine cervix and other gynecologic malignancies
by: Chomporn Sitathanee, et al.
Published: (2018)